Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis

BACKGROUND AND OBJECTIVE: Multi-criteria decision analysis (MCDA) is a tool that systematically considers multiple factors relevant to health decision-making. The aim of this study was to use an MCDA to assess the value of dupilumab for severe atopic dermatitis compared with secukinumab for moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zozaya, Néboa, Martínez-Galdeano, Lucía, Alcalá, Bleric, Armario-Hita, Jose Carlos, Carmona, Concepción, Carrascosa, Jose Manuel, Herranz, Pedro, Lamas, María Jesús, Trapero-Bertran, Marta, Hidalgo-Vega, Álvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990558/
https://www.ncbi.nlm.nih.gov/pubmed/29808418
http://dx.doi.org/10.1007/s40259-018-0284-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990558/
https://www.ncbi.nlm.nih.gov/pubmed/29808418
http://dx.doi.org/10.1007/s40259-018-0284-3

Ejemplares similares